Restoration Recovery outpatient addiction treatment logo
Cannabis Use Disorder · Updated April 2026

Marijuana Addiction Treatment in Tennessee

Evidence-based outpatient care for marijuana addiction and cannabis use disorder — combining cognitive-behavioral therapy, motivational enhancement, intensive outpatient programming, and certified peer support at four clinics across Southeast Tennessee and North Georgia.

Same-day appointments available in most cases · TennCare, BlueCare, BCBS, UHC, and most commercial insurance accepted.

What Is Cannabis Use Disorder?

Marijuana — the everyday name for cannabis — has long been treated culturally as a softer drug. Clinically, the picture is more complicated. About 9% of people who use cannabis develop a use disorder over their lifetime, and that number rises to roughly 17% for people who started using as adolescents. Today's commercial cannabis is also several times more potent than the cannabis of the 1990s, with concentrates and dab products reaching THC levels that simply did not exist a generation ago. The result is a measurable rise in dependence, withdrawal, cannabis-related emergency department visits, and presentations of cannabis-induced psychosis — especially in young, frequent, high-potency users.

Cannabis use disorder (CUD) is a recognized DSM-5 diagnosis, and cannabis withdrawal syndrome was formally added to the DSM-5 in 2013 after years of research confirmed it as a distinct, predictable condition. The criteria for diagnosis mirror the ones used for opioid, alcohol, and stimulant use disorders — loss of control, unsuccessful attempts to cut back, time spent obtaining or using or recovering from cannabis, cravings, neglected responsibilities, continued use despite consequences, tolerance, and withdrawal. None of this requires daily use. Severity ranges from mild to severe, and milder forms often respond well to relatively short courses of structured outpatient counseling.

Unlike opioid or alcohol use disorder, there is no FDA-approved medication-assisted treatment for cannabis use disorder. Researchers have studied dronabinol, nabilone, gabapentin, N-acetylcysteine, and other compounds in clinical trials; none has reached FDA approval for cannabis dependence. The foundation of effective care is therefore behavioral — cognitive-behavioral therapy (CBT), motivational enhancement therapy (MET), the community reinforcement approach (CRA), structured outpatient programming, and peer support. Cochrane systematic reviews of randomized trials have repeatedly shown that combining CBT and MET produces the strongest reductions in cannabis use compared to no treatment or treatment as usual.

Recovery from cannabis use disorder is realistic, often quicker than recovery from heavier drugs, and well-supported by evidence. The data and clinical detail below cover what cannabis use disorder actually looks like clinically, what withdrawal feels like in week one, what treatment looks like when you walk in the door, and how Restoration Recovery's outpatient model fits.

Average THC potency in U.S. cannabis

Confiscated samples, Univ. of Mississippi Potency Monitoring Program

~4% 1995
~14% 2014
15–25% 2020s flower ↑ ~4× vs 1995

Average THC potency in U.S. flower has roughly quadrupled in 25 years. Concentrates and dab products commonly test at 60–90%.

% of cannabis users who develop CUD

Lifetime risk by age of first use

~9% Adult-onset use
~17% Adolescent-onset ↑ ~2× risk

Lifetime risk of cannabis use disorder is about 1 in 11 for adult-onset users and about 1 in 6 for those who started in adolescence.

The Cannabis Picture in 2026

The marijuana most people in Tennessee are using today is not the marijuana of a generation ago.

  • Average THC potency in U.S. flower has risen roughly fourfold from the mid-1990s, climbing from about 4% THC to commonly 15–25% in commercial product.
  • Concentrates and dab products routinely test at 60 to 90% THC, far beyond anything that existed in casual use 20 years ago. Heavy or daily use of these products is associated with higher rates of dependence, withdrawal, and cannabis-induced psychotic episodes.
  • About 9% of people who use cannabis develop a use disorder over their lifetime, with the risk roughly doubling for those who start using in adolescence.
  • Cannabis-related emergency department visits have risen substantially over the past decade, particularly among young adults and people using high-potency concentrates.
  • Polysubstance use is the rule, not the exception. Many patients seeking treatment for cannabis use disorder are also using alcohol, nicotine, or other substances; clinical assessment looks at the whole picture rather than the drug at the top of the intake form.
  • Cannabis is illegal under Tennessee state law in most contexts. Treatment access at Restoration Recovery does not depend on the legal status of the substance — we treat the use disorder regardless of where or how it started, and clinical conversations are protected by 42 CFR Part 2 confidentiality rules.

The practical implication for anyone using cannabis daily today: dependence develops more quickly with high-potency products, withdrawal is real (and the most common reason patients relapse in week one), and the “it's just weed” framing is no longer clinically accurate at modern potency levels. None of that means use is automatically a problem — it does mean that if you suspect your use has crossed into something harder to control, evaluating it with a clinician is reasonable rather than alarmist.

Sources: ElSohly et al., “Changes in Cannabis Potency Over the Last 2 Decades (1995–2014)” (Biological Psychiatry, 2016); American Psychiatric Association DSM-5 Cannabis Use Disorder and Cannabis Withdrawal criteria; Volkow et al., “Adverse Health Effects of Marijuana Use” (NEJM, 2014); SAMHSA National Survey on Drug Use and Health 2023; CDC reports on cannabis-related emergency department visits.

Signs of Cannabis Use Disorder

Cannabis use disorder is a medical condition diagnosed using the DSM-5 criteria. It is not a moral failing, a lack of willpower, or a character defect — it is a brain-based disease of the reward and habit systems that responds to treatment. To meet diagnostic criteria, a person must show a pattern of cannabis use leading to clinically significant impairment or distress, as evidenced by at least two of eleven specific criteria within a 12-month period. Common signs and criteria include:

  • Loss of control. Using more cannabis or for longer periods than intended. A “just one bowl tonight” rule erodes into all-evening use; weekend-only plans become daily.
  • Unsuccessful attempts to cut down. Wanting to stop, taper, or take a break and finding yourself using again, especially in particular situations or emotional states.
  • Time spent on cannabis. Significant time obtaining, using, or recovering from the effects. Mornings spent foggy, afternoons disorganized, evenings re-anchored around use.
  • Cravings. Strong urges to use, often cue-triggered — a particular time of day, location, person, mood, or activity that has become tightly associated with use.
  • Interference with responsibilities. Work performance, school attendance, parenting, or family obligations slipping because of use or its after-effects (slowed thinking, fatigue, mood changes).
  • Continued use despite consequences. Relationship strain, financial cost, school or work problems, legal issues, or health concerns not being enough to stop.
  • Reducing activities. Giving up or scaling back social, occupational, or recreational activities because of cannabis use.
  • Use in risky situations. Using in situations where it is physically hazardous — driving, operating machinery, parenting young children, during pregnancy.
  • Continued use despite psychological or physical problems. Continuing to use even when you know it is worsening anxiety, depression, sleep, motivation, memory, or chronic respiratory symptoms.
  • Tolerance. Needing more cannabis (or stronger products) to feel the same effect, or finding the previous amount no longer produces the same high.
  • Withdrawal. Cannabis withdrawal syndrome — irritability, anxiety, sleep disturbance, decreased appetite, depressed mood, restlessness, and physical symptoms — appearing when use is stopped or sharply reduced.

Two criteria meets the threshold for mild cannabis use disorder; four to five indicates moderate; six or more indicates severe. Severity matters clinically because it guides the intensity of treatment recommended — mild disorder may respond to outpatient counseling alone, while moderate to severe disorder typically benefits from the structured commitment of IOP.

Beyond the diagnostic criteria, long-term heavy cannabis use can leave clinical traces worth mentioning at your evaluation: chronic respiratory symptoms in people who smoke flower, cannabinoid hyperemesis syndrome (cyclical severe vomiting in chronic daily users), worsened sleep architecture once daily use stops, and in some heavy or high-potency users, persistent perceptual changes, paranoia, or cannabis-induced psychotic episodes. Cognitive effects (memory, attention, motivation) typically improve substantially in the weeks and months after stopping, but adolescent-onset heavy use is associated with longer-lasting cognitive changes. If several of the signs above apply to you or someone you care about, a professional evaluation can help clarify where you are and what options exist. You do not need to hit a “rock bottom” before reaching out.

Marijuana Withdrawal: Timeline and Symptoms

Cannabis withdrawal is real, predictable, and the single biggest driver of early-recovery relapse for daily users. It is not life-threatening, and most patients can stop cannabis use safely on an outpatient basis without formal medical detox. The symptoms are largely psychological and somatic rather than physically dangerous — but they are uncomfortable enough that many people who try to stop on their own return to use within days, often telling themselves the next attempt will be easier. Structured support during this window changes the outcome.

Cannabis withdrawal syndrome was added to the DSM-5 in 2013 after years of research established it as a distinct, reproducible condition. A general timeline looks like this:

  • Day 1 to day 3 (onset). Irritability, restlessness, anxiety, and difficulty falling asleep. Vivid or disturbing dreams as REM sleep returns. Decreased appetite. Some patients describe feeling “wired but tired.”
  • Day 2 to day 6 (peak). Symptoms typically peak in this window: sleep is the hardest part, with insomnia and intense dreams; mood is low, irritable, or anxious; appetite is reduced; physical symptoms can include headache, stomach pain, sweating, or chills. Cravings are strong and often cue-triggered.
  • Week 2 (acute resolution). Most symptoms begin lifting. Sleep starts normalizing, though it can remain disrupted for several more weeks. Mood stabilizes. Appetite returns. Cravings become more intermittent, mostly tied to specific people, places, times of day, or emotional states.
  • Week 3 to month 2 (post-acute). Sleep can still be unsettled in heavy long-term users as the brain rebalances. Cue-driven cravings persist but lose intensity. This is the window where IOP, individual counseling, and peer support make the largest difference — the urgent symptoms of week one are gone, but the relapse risk is still meaningful.
  • Month 2 and beyond. Most physical and emotional symptoms resolve. Cognitive function (memory, attention, motivation) improves substantially in adult patients, though adolescent-onset heavy users may see slower or partial recovery. Cravings appear less often and respond well to learned coping strategies.

Because cannabis withdrawal is not physically dangerous, treatment focuses on managing the emotional and behavioral symptoms through counseling, structured programming, and coordinated psychiatric care rather than through a detox medication. For patients with severe anxiety, depression, or insomnia during early recovery, short-term psychiatric medication management can be part of the clinical plan. For the rare patient experiencing cannabis-induced psychotic symptoms, that is a clinical situation that needs immediate attention, and we coordinate with regional partners for a higher level of care if needed before outpatient treatment resumes.

How We Treat Marijuana Addiction

At Restoration Recovery, cannabis use disorder is treated primarily through evidence-based counseling, structured programming, and coordinated medical care. There is no FDA-approved medication-assisted treatment for cannabis dependence, so the foundation of effective care is behavioral. The combination most strongly supported by Cochrane systematic reviews is CBT plus MET, often delivered alongside the community reinforcement approach (CRA) and contingency-management elements within an IOP structure. Treatment components include:

  • Individual counseling with licensed therapists who use evidence-based approaches including cognitive-behavioral therapy (CBT) and motivational enhancement therapy (MET). CBT helps you identify the thought patterns, cues, and behavioral habits that drive cannabis use and replace them with healthier coping strategies. MET addresses the ambivalence that is common in cannabis use disorder — the “part of me wants to stop, part of me doesn't” experience — and strengthens the patient's own motivation for change.
  • The community reinforcement approach and contingency-management elements integrate counseling with structured incentives for documented abstinence and engagement. Decades of research support these approaches for cannabis use disorder, and elements of CRA and contingency management are woven into our counseling and IOP structure.
  • Intensive outpatient programming (IOP) for patients who benefit from a more structured treatment schedule — delivered in IOP's group format by design, with clinician-led sessions multiple times per week. For cannabis use disorder specifically, IOP's group format helps patients move past “is this really a problem?” ambivalence by hearing peers describe similar trajectories.
  • Certified peer support from specialists who have lived experience with recovery themselves. Peer support specialists can talk with you about what it actually feels like to get through the first 30, 60, and 90 days — including the sleep disruption that catches a lot of people off guard — in a way clinical providers who have not been through it cannot.
  • Psychiatric medication management for co-occurring mental health conditions. Many patients with cannabis use disorder also experience anxiety, depression, ADHD, trauma-related conditions, or in some cases bipolar or psychotic-spectrum symptoms — treating these is part of a comprehensive plan. While no medication is FDA-approved for cannabis use disorder itself, psychiatric medications for co-occurring diagnoses are often a critical part of why behavioral treatment works when it works.
  • Integrated care for co-occurring medical conditions, including hepatitis C screening and treatment for patients with risk factors.

Restoration Recovery is an outpatient clinic. We do not provide medical detox or residential care. Because cannabis withdrawal is not physically dangerous, virtually all patients can start outpatient treatment without a formal detox. For patients with cannabis-induced psychotic symptoms, severe co-occurring psychiatric crisis, or active suicidal thinking during early recovery, we coordinate with regional partners for a higher level of care and welcome you back to outpatient treatment when you are stable enough to step down.

What to Expect at Your First Appointment

Your first visit typically lasts 60 to 120 minutes and follows a four-step clinical flow:

  1. Intake. You will complete paperwork and a clinical intake that includes a DSM-5 assessment for cannabis use disorder — a structured review of the eleven diagnostic criteria above, with severity scoring (mild / moderate / severe). The intake also covers your medical history, current health status, current medications, co-occurring mental health conditions (anxiety, depression, ADHD, trauma, bipolar, psychotic-spectrum), and any prior treatment experience. Cannabis use disorder assessment does not use the COWS scale — that is an opioid-specific withdrawal measure. For cannabis, the DSM-5 criteria plus a clinical review of recent use, withdrawal symptoms, and cravings is what guides the plan.
  2. Counseling. You will meet with a counselor to discuss your cannabis use history, prior treatment, current stressors and triggers, ambivalence about stopping, and your personal recovery goals. Because there is no FDA-approved medication for cannabis use disorder, counseling and behavioral interventions form the core of your treatment plan — and this first conversation is how we match you to the right counseling approach (CBT, MET, CRA elements) and the right intensity (weekly individual sessions vs. IOP).
  3. Doctor evaluation. A medical provider reviews your intake and counselor notes, performs a targeted assessment, evaluates any co-occurring psychiatric conditions that may warrant medication (especially anxiety, sleep, and mood symptoms during early withdrawal), screens for polysubstance use, and answers your questions.
  4. Treatment plan. You will leave with a personalized treatment plan, which may include individual counseling, enrollment in our intensive outpatient program (IOP), psychiatric medication for any co-occurring conditions, connection with a certified peer support specialist, and follow-up care. Your first follow-up is scheduled before you leave. Note: unlike opioid use disorder, there is no same-day medication prescription for cannabis — the treatment plan is behavioral, and the “prescription” is the structured commitment to counseling and IOP.

Bring a valid photo ID, your insurance card if applicable, and a list of any medications you currently take. If you have been using other substances alongside cannabis (alcohol, nicotine, opioids, benzodiazepines, stimulants, kratom), bring that history too — polysubstance use is the rule rather than the exception, and it changes the clinical plan.

Why Behavioral Treatment Works for Cannabis Use Disorder

While there is no FDA-approved medication for cannabis use disorder, decades of research support several evidence-based behavioral interventions. Effective treatment typically combines several of these approaches, layered according to severity and patient preference:

  • Cognitive-behavioral therapy (CBT). Helps patients identify the thought patterns, cues, and behavioral habits that drive cannabis use and replace them with healthier coping strategies. Cochrane systematic reviews of randomized trials consistently show CBT reduces cannabis use and improves treatment retention compared to no treatment or treatment as usual.
  • Motivational enhancement therapy (MET). A short-form, structured counseling style that helps patients resolve the ambivalence common to cannabis use disorder — the “part of me wants to stop, part of me doesn't” experience — and strengthen their own motivation for change. Effects are largest when MET is paired with CBT.
  • The community reinforcement approach (CRA). Restructures the patient's social, occupational, and recreational environment so that abstinent activities become more rewarding than continued use. CRA has strong research support specifically for cannabis use disorder and substance use disorders generally.
  • Contingency management. Uses structured incentives for documented abstinence and treatment engagement. Forty-plus years of randomized trials support contingency management for substance use disorders broadly. Elements are woven into our counseling and IOP structure rather than offered as a stand-alone trial.
  • Peer support. Certified peer support specialists provide ongoing accountability, practical guidance, and lived-experience insight that clinicians cannot offer. Peer support is now standard of care in evidence-based outpatient programs.
  • Treatment of co-occurring conditions. Many patients with cannabis use disorder have untreated anxiety, depression, ADHD, PTSD, sleep disorders, or psychotic-spectrum symptoms. Treating these conditions — with therapy, psychiatric medication, or both — is often a critical part of why behavioral treatment works when it works.

Cannabis use disorder is a medical condition that responds to treatment. Recovery is realistic, often quicker than recovery from heavier drugs, and well-supported by evidence. Patients who stay engaged with structured outpatient care have significantly better long-term outcomes than those who attempt to stop on their own. The absence of a medication like buprenorphine does not mean treatment doesn't work; it means the structured commitment to counseling, IOP, and peer support is the treatment.

Why Restoration Recovery

Choosing where to start treatment matters. Restoration Recovery brings together the clinical depth, the practical access, and the kind of care that keeps patients in treatment long enough to get well.

  • Chattanooga's longest-running outpatient addiction treatment clinic. Our providers have decades of clinical experience treating substance use disorders in Southeast Tennessee — including cannabis use disorder presentations across the full severity spectrum.
  • CARF accredited. The Commission on Accreditation of Rehabilitation Facilities is the gold standard for outpatient addiction care — our accreditation is reviewed on an ongoing basis, not a one-time stamp.
  • Four clinic locations across Southeast Tennessee and North Georgia, with telehealth follow-up available for established patients.
  • Most major insurance accepted — TennCare, Georgia Medicaid, commercial plans, Medicare, and supplemental Medicare. Our patient services team verifies your benefits before your first visit so there are no surprises.
  • Same-day appointments in most cases. You don't have to wait weeks to start.
  • One integrated team. Medical providers, counselors, certified peer support specialists, and psychiatric care under one roof — not parallel referral tracks that leave you coordinating your own care.
  • Licensed in both states. Licensed in Tennessee and Georgia, HIPAA compliant, 42 CFR Part 2 compliant — your treatment is confidential from the first phone call.
  • Polysubstance-ready clinical team. Most cannabis-use-disorder patients also use alcohol, nicotine, or other substances at presentation. We are built to treat the whole picture, not just the drug at the top of the intake form.

Insurance and Access

Restoration Recovery accepts most major insurance plans, including TennCare, Georgia Medicaid, a broad range of commercial plans, and Medicare (plus supplemental Medicare plans). Our patient services team can verify your benefits before your first appointment so you know exactly what to expect in terms of cost.

If you do not have insurance, contact us anyway. We can help you explore options and will walk you through self-pay pricing. For a full list of accepted carriers and details on the verification process, visit our insurance page.

Four Clinic Locations

We operate four outpatient clinics across Southeast Tennessee and North Georgia. All locations offer marijuana addiction treatment with same-day appointments in most cases:

  • Chattanooga, TN — 6141 Shallowford Rd, Suite 100, Chattanooga, TN 37421
  • Cleveland, TN — Serving Bradley County and surrounding areas
  • Soddy-Daisy, TN — Serving Hamilton County north and the Sequatchie Valley
  • Ringgold, GA — Serving Catoosa County and Northwest Georgia

Telehealth follow-up visits are available for established patients who have completed their initial in-person evaluation. For directions, hours, and contact information, visit our locations page.

Frequently Asked Questions

Is marijuana really addictive?

Yes. Cannabis use disorder is a recognized DSM-5 diagnosis with documented withdrawal syndrome, tolerance, and patterns of compulsive use that persist despite negative consequences. About 9% of people who use cannabis develop a use disorder, rising to about 17% for people who start using in adolescence. Today's commercial cannabis is also substantially more potent than the cannabis of even 20 years ago, which raises the dependence and adverse-effect risk further. The “it's just weed” framing is outdated; the clinical reality is that cannabis use disorder is real, common, and treatable.

Can you treat cannabis use disorder without medication?

Yes. There is no FDA-approved medication-assisted treatment for cannabis use disorder — and the absence of a medication does not mean treatment doesn't work. The foundation of effective care is behavioral: cognitive-behavioral therapy (CBT), motivational enhancement therapy (MET), the community reinforcement approach (CRA), intensive outpatient programming (IOP), and certified peer support. Cochrane systematic reviews of randomized trials show that combining CBT and MET produces the strongest reductions in cannabis use compared to no treatment or treatment as usual. If you also have anxiety, depression, ADHD, or trauma alongside cannabis use, psychiatric medication can treat those co-occurring conditions as part of a comprehensive plan.

Is marijuana withdrawal real?

Cannabis withdrawal syndrome was added to the DSM-5 in 2013 after years of research established it as a distinct, predictable condition. Common symptoms include irritability or anger, anxiety, sleep disturbance with vivid dreams, decreased appetite, depressed mood, restlessness, and physical symptoms like headaches, stomach pain, or sweating. Symptoms typically begin within 1 to 3 days of stopping, peak around days 2 to 6, and resolve over 1 to 2 weeks, though sleep disturbance can persist longer in heavy long-term users. Withdrawal is not life-threatening, but it is the single biggest driver of early-recovery relapse for daily users — which is exactly where structured outpatient care, counseling, and peer support during the first weeks make the largest difference.

How does IOP work for cannabis use disorder?

Intensive outpatient programming (IOP) is a structured treatment schedule where you attend clinician-led sessions multiple times per week while continuing to live at home. A typical IOP commitment at Restoration Recovery is nine hours per week delivered across three sessions, which meets the definition of IOP under ASAM level-of-care criteria. The format is group-based by design, and for cannabis use disorder specifically, peer accountability and shared coping strategies help patients work through the cue-driven cravings and ambivalence that often drive relapse. IOP is not residential or inpatient care; you go home each night, keep working if your schedule allows, and step down to less intensive outpatient care as you stabilize.

What if I am only using marijuana — do I really need treatment?

You can decide that for yourself by looking at the DSM-5 criteria for cannabis use disorder. If you have tried to cut back without success, find yourself using more or longer than intended, have lost interest in activities you used to enjoy, are experiencing problems with work, school, relationships, or mood that you suspect are tied to use, or notice withdrawal-like symptoms when you stop, those are reasons to talk to a clinician. Treatment is not just for severe cases. Patients with mild to moderate cannabis use disorder often respond well to a relatively short course of structured outpatient counseling. Reaching out earlier means a shorter, lighter intervention than waiting until the disorder is severe.

Can high-potency THC products like wax or dabs cause psychosis?

Heavy, frequent use of high-potency THC products is associated with an increased risk of cannabis-induced psychotic episodes, particularly in younger users and people with a personal or family history of psychotic disorders. Most patients who experience these episodes recover with abstinence, supportive care, and short-term psychiatric medication if needed. If you have experienced cannabis-induced psychosis, paranoia that did not resolve after stopping, or ongoing perceptual changes, that is a clinical situation that needs immediate attention. Tell your provider at intake; this affects the treatment plan and the level of care recommended.

Take the Next Step

Marijuana addiction is treatable, and most patients see meaningful change within weeks of starting structured outpatient care. You don't have to figure this out alone — and you don't need to have all the answers before you call. You don't need to be abstinent before your first appointment. Our team will walk you through the process from your first phone call to your first visit and every follow-up after that.

Same-day appointments are available in most cases. Contact us today to schedule your evaluation, or call 423-498-2000 to speak with our team directly.

A place for hope & healing

Ready to start marijuana addiction treatment?

Same-day appointments in most cases. Most major insurance plans accepted.